50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
NYSE:GMRE

Global Medical REIT - GMRE Stock Forecast, Price & News

$8.74
+0.19 (+2.22%)
(As of 09/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.47
$8.87
50-Day Range
$8.55
$12.23
52-Week Range
$8.47
$18.51
Volume
540,923 shs
Average Volume
407,700 shs
Market Capitalization
$572.63 million
P/E Ratio
46.00
Dividend Yield
9.82%
Price Target
$16.50

Global Medical REIT MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
88.8% Upside
$16.50 Price Target
Short Interest
Bearish
10.10% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
0.30mentions of Global Medical REIT in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.32%
From $0.95 to $1.01 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Finance Sector

430th out of 923 stocks

Real Estate Investment Trusts Industry

98th out of 197 stocks

GMRE stock logo

About Global Medical REIT (NYSE:GMRE) Stock

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Stock News Headlines

Global Medical REIT Now Has A 9% Recession Resistant Yield
Flying Under The Radar: 3 Small-Cap Healthcare REIT Gems
Short Volatility Alert: Global Medical REIT Inc.
3 Health Care REITs To Help You Sleep Well At Night
Summit Hotel Properties (INN) Misses Q2 FFO Estimates
SL Green (SLG) Q2 FFO Surpass Estimates
Global Medical REIT Inc - Stock Dividends GMRE
Global Medical REIT: Nearing Escape Velocity
Global Medical REIT (GMRE) Q1 FFO Lag Estimates
Global Medical REIT Q1 2022 Earnings Preview
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 7/8 Dividend
6/23/2022
Dividend Payable
7/08/2022
Ex-Dividend for 10/11 Dividend
9/22/2022
Today
9/28/2022
Dividend Payable
10/11/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.50
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+88.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$17.62 million
Pretax Margin
15.07%

Debt

Sales & Book Value

Annual Sales
$115.94 million
Cash Flow
$1.03 per share
Book Value
$8.76 per share

Miscellaneous

Free Float
60,539,000
Market Cap
$572.63 million
Optionable
Optionable
Beta
0.96

Key Executives

  • Mr. Jeffery M. BuschMr. Jeffery M. Busch (Age 62)
    Chairman, Pres & CEO
    Comp: $966.79k
  • Mr. Robert J. Kiernan CPA (Age 56)
    CFO & Treasurer
    Comp: $539.79k
  • Ms. Danica C. Holley (Age 49)
    Chief Operating Officer
    Comp: $378.26k
  • Mr. Alfonzo Leon (Age 46)
    Chief Investment Officer
    Comp: $499.51k
  • Mr. Jamie A. Barber (Age 45)
    Gen. Counsel & Corp. Sec.
    Comp: $372.26k
  • Ms. Mary Jensen
    Investor Relations Professional













GMRE Stock - Frequently Asked Questions

Should I buy or sell Global Medical REIT stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GMRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMRE, but not buy additional shares or sell existing shares.
View GMRE analyst ratings
or view top-rated stocks.

What is Global Medical REIT's stock price forecast for 2022?

1 equities research analysts have issued twelve-month price objectives for Global Medical REIT's stock. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they predict the company's stock price to reach $16.50 in the next twelve months. This suggests a possible upside of 88.6% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How have GMRE shares performed in 2022?

Global Medical REIT's stock was trading at $17.75 at the beginning of 2022. Since then, GMRE shares have decreased by 50.7% and is now trading at $8.75.
View the best growth stocks for 2022 here
.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest in August. As of August 15th, there was short interest totaling 1,610,000 shares, an increase of 9.5% from the July 31st total of 1,470,000 shares. Based on an average trading volume of 401,400 shares, the days-to-cover ratio is presently 4.0 days. Approximately 10.6% of the shares of the stock are short sold.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) announced its earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a net margin of 13.31% and a trailing twelve-month return on equity of 2.95%. During the same period last year, the firm posted $0.24 earnings per share.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Friday, September 9th. Investors of record on Friday, September 23rd will be given a dividend of $0.21 per share on Tuesday, October 11th. This represents a $0.84 dividend on an annualized basis and a yield of 9.60%. The ex-dividend date is Thursday, September 22nd.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 9.47%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 442.13%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 83.17% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different institutional and retail investors. Top institutional shareholders include State Street Corp (2.85%), Brown Advisory Inc. (1.93%), Brown Advisory Inc. (1.91%), Aew Capital Management L P (1.52%), State of New Jersey Common Pension Fund D (1.50%) and Prudential Financial Inc. (1.35%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $8.75.

How much money does Global Medical REIT make?

Global Medical REIT (NYSE:GMRE) has a market capitalization of $573.30 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.19 on an earnings per share basis.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.

This page (NYSE:GMRE) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.